7th Feb 2023 21:31
(Alliance News) - Arix Bioscience PLC said on Monday its net asset value at January 31 was 180 pence, down from 182p at the end of October, 2022.
London-based Arix added its total portfolio NAV at January 31 was GBP232.9 million, down from GBP235.4 as of October 31, 2022.
Arix Bioscience is a venture capital company focused on investing in biotechnology companies. Shares in firm closed up 2.80% at 110p in London on Tuesday.
By Jeremy Cutler, Alliance News reporter.
Comments and questions to [email protected].
Copyright 2023 Alliance News Ltd. All Rights Reserved.
Related Shares:
ARIX.L